ArticleProstate cancer and prostatic diseases2016

Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenografts.

J A Gordon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.